Novartis Pharmaceutical Corporation / Mei / M.S. / /
Event
FDA Phase / /
Facility
Children’s Hospital / Laboratory Presentations Hira Nakhasi / Research Center / Laboratory of Plasma Derivatives / University College London / Laboratory of Hemostasis / /
MedicalCondition
chronic iron / transfusional hemosiderosis / /
MedicalTreatment
blood transfusions / /
Movie
Conflict of Interest / /
Organization
Laboratory of Plasma Derivatives / office of Blood Research / Research Center / PRODUCTS ADVISORY COMMITTEE / Oncology Business Unit / University College London / Laboratory of Hemostasis / Laboratory of Hemostasis and the Laboratory of Plasma Derivatives / Department of Hematology/Oncology / FDA / Division of Hematology / Children’s Hospital / Blood Products Advisory Committee / Department of Hematology / /
Person
Basal Golding / Dorothy Scott / George Mills / Donald W. Jehn / John Porter / George G. Shashaty / Yu / Jay Lozier / Peter Marks / Basil Golding / James R. Allen / Elliott Vichinsky / P.K. Narang / Hira Nakhasi / /
Position
Professor / Director / Executive Secretary / Director / Division of Medical Imaging and Hematology Products / Porter / Medical Officer / CDER / Vice President / Global / Acting Associate Director / M.P.H. Chair / Chief / /
Microsoft Word[removed]4177A1_final.doc